RecruitingNot ApplicableNCT06327750

The Microcirculation, Dialysis Modality and Sequestered Salt


Sponsor

Amsterdam UMC, location VUmc

Enrollment

23 participants

Start Date

Jun 2, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of this clinical trial is to investigate the effect of 5 different dialysis treatments (combinations of dialysis mode and dialysis fluid sodium content) on the microcirculation (MC) and sequestered sodium content (SSC) in adult prevalent end-stage kidney disease (ESKD) patients treated with hemodialysis (HD) or hemodiafiltration (HDF). The main questions it aims to answer are: 1. What are the effects on the sequestered sodium content and microcirculation after 4 weeks of treatment with the following dialysis modes? * HDF with an expected zero diffusive sodium balance (Dialysate sodium concentration (DNa)= Plasma sodium concentration (PNa)) compared to * HDF with an expected diffusive sodium efflux (DNa \< PNa, difference 3 mmol/L) compared to * HD with an expected zero diffusive sodium balance (DNa = PNa) compared to * HD with an expected diffusive sodium efflux (DNa \< PNa, difference 3 mmol/L) compared to * Isolated ultrafiltration for 30 minutes followed by HD with an expected zero diffusive sodium balance (DNa = PNa) 2. Are the SSC and MC interrelated in this patient group? This study is a randomized cross-over trial. Participants will be subjected to the abovementioned dialysis treatment modes in random order.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Hemodialysis (DNa = PNa), a medical device called Hemodialysis (DNa<PNa), and others for people with end stage renal disease. The study is currently recruiting participants at 2 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEHemodialysis (DNa = PNa)

High-flux hemodialysis with an expected zero diffusive sodium balance (DNa = PNa)

DEVICEHemodialysis (DNa<PNa)

High-flux hemodialysis with expected diffusive sodium efflux (DNa\<PNa, difference: 3 mmol/L)

DEVICEHemodialysis after isolated ultrafiltration (DNa=PNa)

High-flux hemodialysis after isolated ultrafiltration with an expected zero diffusive sodium balance (DNa=PNa)

DEVICEHigh volume hemodiafiltration (DNa=PNa)

High volume hemodiafiltration with an expected zero diffusive sodium balance (DNa=PNa) Convection volume: ≥23L/session

DEVICEHigh volume hemodiafiltration (DNa<PNa)

High volume hemodiafiltration with expected diffusive sodium efflux (DNa\<PNa, difference: 3 mmol/L) Convection volume: ≥23L/session


Locations(2)

Niercentrum aan de Amstel (Elyseklinieken)

Amstelveen, North Holland, Netherlands

Dianet Amsterdam

Amsterdam, North Holland, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06327750


Related Trials